Dr Michael David Weiland Jr, MD | |
1319 Jefferson Hwy, New Orleans, LA 70121-2406 | |
(504) 842-3900 | |
(504) 842-5848 |
Full Name | Dr Michael David Weiland Jr |
---|---|
Gender | Male |
Speciality | Pediatric Medicine |
Experience | 12 Years |
Location | 1319 Jefferson Hwy, New Orleans, Louisiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003172248 | NPI | - | NPPES |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Ochsner Clinic Llc | 8224933619 | 2403 |
News Archive
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Biocon, Limited (NSE: BIOCON) announced today that they have entered into an exclusive agreement to jointly develop, commercialize and manufacture a novel peptide therapeutic for the potential treatment of diabetes. Amylin and Biocon will collaborate to develop the therapeutic potential of the compound and share development costs. Research will center on Amylin's "phybrid" technology.
Glioblastomas are incurable malignant brain tumors. Usually the patients affected survive for only a few months.
"Because non-melanoma skin cancers generally occur in persons after 50, very little attention has been paid to their incidence in younger adults and children," says Leslie Christenson, M.D., Mayo Clinic dermatologist and lead investigator of the study.
Ingenix, a leading provider of health information, technology and consulting services, and A-Life Hospital, a wholly owned subsidiary of A-Life Medical, today announced an agreement to connect the Ingenix Web.Strat™ encoder with Actus®, A-Life Hospital's computer-assisted coding (CAC) application.
By tuning into a subset of brain waves, University of Michigan researchers have dramatically reduced the power requirements of neural interfaces while improving their accuracy-a discovery that could lead to long-lasting brain implants that can both treat neurological diseases and enable mind-controlled prosthetics and machines.
› Verified 9 days ago
Entity Name | Ochsner Clinic Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1538151428 PECOS PAC ID: 8224933619 Enrollment ID: O20031126000513 |
News Archive
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Biocon, Limited (NSE: BIOCON) announced today that they have entered into an exclusive agreement to jointly develop, commercialize and manufacture a novel peptide therapeutic for the potential treatment of diabetes. Amylin and Biocon will collaborate to develop the therapeutic potential of the compound and share development costs. Research will center on Amylin's "phybrid" technology.
Glioblastomas are incurable malignant brain tumors. Usually the patients affected survive for only a few months.
"Because non-melanoma skin cancers generally occur in persons after 50, very little attention has been paid to their incidence in younger adults and children," says Leslie Christenson, M.D., Mayo Clinic dermatologist and lead investigator of the study.
Ingenix, a leading provider of health information, technology and consulting services, and A-Life Hospital, a wholly owned subsidiary of A-Life Medical, today announced an agreement to connect the Ingenix Web.Strat™ encoder with Actus®, A-Life Hospital's computer-assisted coding (CAC) application.
By tuning into a subset of brain waves, University of Michigan researchers have dramatically reduced the power requirements of neural interfaces while improving their accuracy-a discovery that could lead to long-lasting brain implants that can both treat neurological diseases and enable mind-controlled prosthetics and machines.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Michael David Weiland Jr, MD 1514 Jefferson Hwy, New Orleans, LA 70121-2429 Ph: (504) 842-4000 | Dr Michael David Weiland Jr, MD 1319 Jefferson Hwy, New Orleans, LA 70121-2406 Ph: (504) 842-3900 |
News Archive
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Biocon, Limited (NSE: BIOCON) announced today that they have entered into an exclusive agreement to jointly develop, commercialize and manufacture a novel peptide therapeutic for the potential treatment of diabetes. Amylin and Biocon will collaborate to develop the therapeutic potential of the compound and share development costs. Research will center on Amylin's "phybrid" technology.
Glioblastomas are incurable malignant brain tumors. Usually the patients affected survive for only a few months.
"Because non-melanoma skin cancers generally occur in persons after 50, very little attention has been paid to their incidence in younger adults and children," says Leslie Christenson, M.D., Mayo Clinic dermatologist and lead investigator of the study.
Ingenix, a leading provider of health information, technology and consulting services, and A-Life Hospital, a wholly owned subsidiary of A-Life Medical, today announced an agreement to connect the Ingenix Web.Strat™ encoder with Actus®, A-Life Hospital's computer-assisted coding (CAC) application.
By tuning into a subset of brain waves, University of Michigan researchers have dramatically reduced the power requirements of neural interfaces while improving their accuracy-a discovery that could lead to long-lasting brain implants that can both treat neurological diseases and enable mind-controlled prosthetics and machines.
› Verified 9 days ago
Dr. Walter Jordan Hoyt Jr., M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1514 Jefferson Hwy, New Orleans, LA 70121 Phone: 504-842-3900 Fax: 504-842-5647 | |
Dr. Brian Barkemeyer, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 200 Henry Clay Ave, New Orleans, LA 70118 Phone: 504-896-9418 | |
Dr. James Robinson, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1415 Tulane Ave, New Orleans, LA 70112 Phone: 504-988-2300 Fax: 504-988-8886 | |
Dr. Brandace J Hider, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2820 Napoleon Ave Ste 950, New Orleans, LA 70115 Phone: 504-897-4242 | |
Dr. Lutifat Kashimawo, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1514 Jefferson Hwy, New Orleans, LA 70121 Phone: 504-842-4000 | |
Rodolfo E Begue, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 200 Henry Clay Ave, New Orleans, LA 70118 Phone: 504-896-9583 |